Zenith® Fenestrated+ Clinical Study (NCT04875429)
Zenith® Fenestrated+ Endovascular Graft Clinical Study
🩺 Plain-English Summary (8th-Grade Level)
The Zenith® Fenestrated+ Endovascular Graft Clinical Study will assess the safety and effectiveness of the Zenith® Fenestrated+ Endovascular Graft (ZFEN+) in combination with the BeGraft Balloon-Expandable FEVAR Bridging Stent Graft System (BeGraft) and Unibody2 for the treatment of patients with aortic aneurysms involving one or more of the major visceral arteries. Up to 60 additional subjects may be enrolled in Continued Access phase of the study
Who can join: Review the eligibility criteria below.
Location: University of Alabama Birmingham Hospital — Birmingham, Alabama
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (33 Sites)
Showing the first 25 of 33 sites.
- University of Alabama Birmingham Hospital — Birmingham, Alabama
- UC San Diego — La Jolla, California
- University of Southern California — Los Angeles, California
- Stanford Hospitals and Clinics — Stanford, California
- Medstar Washington Hospital Center — Washington D.C., District of Columbia
- University of Florida Shands Hospital — Gainesville, Florida
- Tampa General Hospital — Tampa, Florida
- Emory University Hospital — Atlanta, Georgia
- Northwestern Memorial Hospital — Chicago, Illinois
- Endeavor Health Cardiovascular Institute at Glenbrook Hospital — Glenview, Illinois
- Loyola University Medical Center — Maywood, Illinois
- Edward Hospital — Naperville, Illinois
- Methodist Hospital of Indiana — Indianapolis, Indiana
- University of Maryland — Baltimore, Maryland
- Massachusetts General Hospital — Boston, Massachusetts
- Beth Israel Deaconess Medical Center — Boston, Massachusetts
- University of Massachusetts — Worcester, Massachusetts
- University of Michigan Health System — Ann Arbor, Michigan
- Mayo Clinic — Rochester, Minnesota
- Barnes Jewish Hospital — St Louis, Missouri
- Dartmouth-Hitchcock Medical Center — Lebanon, New Hampshire
- New York University Langone Medical Center — New York, New York
- Columbia University Irving Medical Center/NY Presbyterian Hospital — New York, New York
- University of North Carolina at Chapel Hill — Chapel Hill, North Carolina
- Cleveland Clinic Foundation — Cleveland, Ohio
📞 Contact the Study Coordinator
Phone: (765) 463-7537
Email: chanda.bell@cookmedical.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Aortic Aneurysm, Abdominal
- Assessment of the GORE® EXCLUDER® Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms — Birmingham, Alabama
- AAA-SHAPE Pivotal Trial: Abdominal Aortic Aneurysm Sac Healing and Prevention of Expansion — Birmingham, Alabama
- Clinical Outcomes of Patients Treated With Open Surgical Repair for Complex Aortic Aneurysms — Rochester, Minnesota
- Comparison of EVAR and ESAR for Infrarenal Aortic Aneurysms With a Wide Proximal Neck — Washington, Arkansas
- ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES — La Jolla, California
Explore by condition: All Aortic Aneurysm, Abdominal clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.